Solara Active Pharma Sciences Limited (NSE:SOLARA) — Market Cap & Net Worth
Market Cap & Net Worth: Solara Active Pharma Sciences Limited (SOLARA)
Solara Active Pharma Sciences Limited (NSE:SOLARA) has a market capitalization of $290.27 Million (Rs26.84 Billion) as of September 19, 2026. Listed on the NSE stock exchange, this India-based company holds position #15089 globally and #759 in its home market, demonstrating a 7.47% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Solara Active Pharma Sciences Limited's stock price Rs742.05 by its total outstanding shares 36171307 (36.17 Million). Also see SOLARA total assets for a full breakdown of the balance sheet.
Solara Active Pharma Sciences Limited Market Cap History: 2018 to 2026
Solara Active Pharma Sciences Limited's market capitalization history from 2018 to 2026. Data shows growth from $118.18 Million to $290.27 Million (14.40% CAGR). Also see how efficiently does Solara Active Pharma Sciences Limited generate cash for how efficiently the company converts equity into cash flow.
Index Memberships
Solara Active Pharma Sciences Limited is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.18 Trillion | 0.01% | #538 of 750 |
Weight: Solara Active Pharma Sciences Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Solara Active Pharma Sciences Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Solara Active Pharma Sciences Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check SOLARA stock price and chart for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.02x
Solara Active Pharma Sciences Limited's market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
40.93x
Solara Active Pharma Sciences Limited's market cap is 40.93 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $118.18 Million | $5.21 Billion | $3.77 Million | 0.02x | 31.35x |
| 2019 | $168.62 Million | $13.22 Billion | $595.27 Million | 0.01x | 0.28x |
| 2020 | $465.29 Million | $12.68 Billion | $1.15 Billion | 0.04x | 0.41x |
| 2021 | $399.39 Million | $15.97 Billion | $2.21 Billion | 0.03x | 0.18x |
| 2022 | $168.29 Million | $12.68 Billion | -$581.50 Million | 0.01x | N/A |
| 2023 | $141.27 Million | $14.27 Billion | -$221.70 Million | 0.01x | N/A |
| 2024 | $265.53 Million | $12.89 Billion | -$5.67 Billion | 0.02x | N/A |
| 2025 | $221.00 Million | $12.84 Billion | $5.40 Million | 0.02x | 40.93x |
Competitor Companies of SOLARA by Market Capitalization
Companies near Solara Active Pharma Sciences Limited in the global market cap rankings as of September 19, 2026. Review Solara Active Pharma Sciences Limited tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Solara Active Pharma Sciences Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #613 globally with a market cap of $44.92 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #670 globally with a market cap of $40.99 Billion USD ( CN¥280.10 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #613 | GALDERMA GROUP AG | NYSE:GALDY | $44.92 Billion | $38.53 |
| #635 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.90 |
| #670 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $40.99 Billion | CN¥43.91 |
Solara Active Pharma Sciences Limited Historical Marketcap From 2018 to 2026
Between 2018 and today, Solara Active Pharma Sciences Limited's market cap moved from $118.18 Million to $ 290.27 Million, with a yearly change of 14.40%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs290.27 Million | +31.35% |
| 2025 | Rs221.00 Million | -16.77% |
| 2024 | Rs265.53 Million | +87.96% |
| 2023 | Rs141.27 Million | -16.05% |
| 2022 | Rs168.29 Million | -57.86% |
| 2021 | Rs399.39 Million | -14.16% |
| 2020 | Rs465.29 Million | +175.94% |
| 2019 | Rs168.62 Million | +42.68% |
| 2018 | Rs118.18 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Solara Active Pharma Sciences Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $290.27 Million USD |
| MoneyControl | $290.27 Million USD |
| MarketWatch | $290.27 Million USD |
| marketcap.company | $290.27 Million USD |
| Reuters | $290.27 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally. The company offers APIs for amyotrophic lateral sclerosis, anesthetics, anthelmintic, anti hyperlipidemic, anti-arr… Read more